(Q45914293)

17 December 2017

review article

1 reference

title

Diagnosing patients with hereditary paraganglial tumours. (English)

1 reference

17 December 2017

author name string

Zoran Erlic

series ordinal

1

1 reference

17 December 2017

Hartmut P H Neumann

series ordinal

2

1 reference

17 December 2017

publication date

1 August 2009

1 reference

17 December 2017

Lancet Oncology Commission

published in

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

8

1 reference

17 December 2017

page(s)

741

1 reference

17 December 2017

Germ-line mutations in nonsyndromic pheochromocytoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970204-9

7 January 2021

Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970204-9

7 January 2021

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970204-9

7 January 2021

American Society of Clinical Oncology Policy Statement Update: Genetic Testing for Cancer Susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970204-9

7 January 2021

When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970204-9

7 January 2021

10.1016/S1470-2045(09)70204-9

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017